Worldwide, 880,000 people die each year as a result of infection with the hepatitis B virus (HBV). Antiviral drugs that can suppress replication of the virus are available. However, these must be taken for decades, as there ...
Jul 28, 2022
0
3
Repurposed drugs may have a speedier path to clinical use because they have already been shown to be safe in people. A study publishing May 19 in the open access journal PLOS Pathogens by Sandrine Belouzard and Jean Dubuisson ...
May 19, 2022
0
25
No one's exactly sure what causes Bell's palsy, a condition that causes sudden facial weakness on one side of the face. But the symptoms are unmistakable. Once the weakness, or paralysis, sets in—usually on one side of ...
May 9, 2022
0
5
Overshadowed by the global push for vaccines, the search for treatments for COVID-19 has made steady—if slower—progress.
Sep 27, 2021
0
31
A new study indicates that protein kinases, which initiate the process that erodes the body's immunity, significantly contribute to the immunodeficiency in HIV patients. Drugs that block these protein kinases may offer a ...
Mar 1, 2021
0
18
The U.S. Preventive Services Task Force (USPSTF) concludes that screening adults and adolescents at increased risk for hepatitis B virus (HBV) infection has moderate net benefit. These findings form the basis of a final recommendation ...
Dec 16, 2020
0
0
A new therapy for influenza virus infections that may also prove effective against many other pathogenic virus infections, including HIV and COVID-19, has been developed by Purdue University scientists.
Nov 24, 2020
0
42
New research presented at this week's ESCMID Conference on Coronavirus Disease (ECCVID, held online) shows that a shorter time from symptom onset to hospitalisation is associated with more serious disease and death in patients ...
Sep 26, 2020
0
7
University of Alberta researchers are racing against the clock to test an antiviral drug that has been proven to cure a cat coronavirus and is hoped to have the same effect on people with COVID-19.
Apr 1, 2020
0
130
New direct-acting antiviral therapies are highly effective at eliminating the Hepatitis C virus infection, according to a systematic evidence review by researchers at Oregon Health & Science University.
Mar 3, 2020
0
17
